However, a decrease in systolic blood pressure was observed in the supplement group, and a significant interaction was found between DHA supplementation and APOE ɛ4 carrier status, indicating improvements in depression and anxiety scores among carriers (Mengelberg et al. 2022). This evidence concerns the gene APOE and depressive symptom measurement.